Chronic disease as a barrier to breast and cervical cancer screening

Journal of General Internal Medicine

Volumn 13, Issue 6, 1998, Pages 357-365

  Kiefe, Catarina I ^a,b   Funkhouser, Ellen ^a   Fouad, Mona N ^a   May, Daniel S ^c  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Breast cancer; Cervical cancer; Comorbidity; Mass screening

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER SCREENING; CHRONIC DISEASE; COMORBIDITY; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTPATIENT CARE; PAPANICOLAOU TEST; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; BREAST NEOPLASMS; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0031751358     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.1998.00115.x     Document Type: Article

References (57)

1. La Vecehia C, Decarli A, Gentile A, et al. Pap smear and the risk of cervical neoplasia: quantitative estimates from a case-control study. Lancet. 1984;2:779-82.
2. Kerlikowske K, Grady D. Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995; 273(2): 149-54.
3. US Preventive Services Task Force, Guide to Clinical Prevention Services. 2nd ed. Baltimore, Md: Williams & Wilkins: 1996.
4. Anderson LM, May DS. Has the use of the cervical, breast. and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85(6):840-2.
5. Trends in cancer screening - United States. 1987 and 1992. MMWR. 1996;45(3):57-61.
6. Bastani R, Marcus AC, Hollatz-Brown A. Screening mammography rates and barriers to use: a Los Angeles County survey. Prev Mod. 1991;20:350-63.
7. Love RR, Brown RL, Davls JE, Baumann LJ, Fontana SA, Sanner LA. Frequency and determinants of screening for breast cancer in primary care group practice. Arch Intern Med. 1993;153:2113-7.
8. Dolan NC, Reifler DR, McDermott MM, McGaghie WC. Adherence to screening mammography recommendations in a university general medicine clinic. J Gen Intern Med. 1995;10:299-306.
9. Grady KE, Lemkau JP, McVay JM, et al. Clinical decision-making and mammography referral. Prev Med. 1996;25:327-38.
10. Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines: barriers and enhances. J Am Board Fam Pract. 1992;5(2):143-52.
11. Kiefe CI, McKay SV, Halevy A, Brody AB. Is cost a barrier to screening mammography for low-income women receiving Medicare benefits? A randomized trial. Arch Intern Med. 1994;154:1217-24.
12. Herman CJ, Speroff T, Cebul RD. Improving compliance with breast cancer screening in older women. Results of a randomized controlled trial. Arch Intern Med. 1995;155:717-22.
13. Zapka JG, Harris DR, Hosmer D, Costanza ME, Mas E, Barth R. Effect of a community health center intervention on breast cancer screening among Hispanic American women. Health Serv Res. 1993;28(2):223-35.
14. Flelcher SW, Harris RP, Gonzalez JJ, et al. Increasing mammography utilization: a controlled study. J Natl Cancer Inst. 1993;85(2): 112-20.
15. Luke K. Cervical cancer screening: meeting the needs of minority ethnic women. Br J Cancer. 1996:29(suppl):S47-50.
16. McGregor SE, Leinweber CE. Involving family physicians in education programs for cervical cancer screening. Ann NY Acad Sci. 1995;768:289-91.
17. Orbell S, Crombie I, Robertson A, Johnston G, Kenicer M. Assessing the effectiveness of a screening campaign: who is missed by 80% cervical screening coverage? J R Soc Med. 1995;88(7):389-94.
18. Lubitz RM, Litzelman DK, Dittus RS, Tierney WM. Is obesity a barrier to physician screening for cervical cancer? Am J Med. 1995;98(5):491-6.
19. Austoker J. Cancer prevention in primary care. Screening for cervical cancer. BMJ. 1994;309(6949):241-8. Review. Published erratum appears in BMJ. 1994;309(6952):452.
20. Smith RA, Haynes S. Barriers to screening for breast cancer. Cancer. 1992;69(7 suppl): 1968-78. Review.
21. Satariano WA. Comorbidity and functional status in older women with breast cancer: implications for screening, treatment, and prognosis. J Gerontol. 1992;47:24-31.
22. Hoffman C, Rice DP. Chronic Care in America: A 21st Century Challenge, Princeton, NJ: Robert Wood Johnson Foundation: 1996.
23. Bostick RM, Sprafka JM, Vimig BA, Potter JD. Predictors of cancer prevention attitudes and participation in cancer screening examinations. Prev Med. 1994;23:816-26.
24. Grady KE, Lemkau JP, McVay JM, Reisine ST. The importance of physician encouragement in breast cancer screening of older women. Prev Med. 1992;21:766-80.
25. Burack RC, Liang J. The acceptance and completion of mammography by older black women. Am J Public Health. 1989;79(6):721-6.
26. Shoen RE, Marcus M, Braham RL. Factors associated with the use of screening mammography in a primary care setting. J Community Health. 1994;19(4):239-52.
27. Rosner BA. Fundamentals of Biostatistics. 4th ed. Belmont, Calif: Wadsworth: 1995.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373-83.
29. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-51.
30. US Preventive Services Task Force. Guide to Clinical Preventive Services. Baltimore, Md: Williams & Wilkins: 1989.
31. Mandelblatt J, Traxler M, Lakin P, et al. Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Am J Prev Med. 1993;9(3):133-8.
32. US Department of Health and Human Services. Healthy People 2000. Washington. DC: Public Health Service; 1990.
33. US Department of Health and Human Services. Healthy People 2000. Midcourse Review and 1995;Revisions. Washington. DC: Public Health Service; 1995.
34. Dolan NC, Reifler DR, McDermott MM, McGaghie WC. Adherence to screening mammography recommendations in a university general medicine clinic. J Gen Intern Med. 1995;10:299-306.
35. Ackermann SP, Cheal N. Factors affecting physician adherence to breast cancer screening guidelines. J Cancer Educ. 1994;9(2): 96-100.
36. Chao A, Paganini-Hill A, Ross RK, Henderson BE. Use of preventive care by the elderly. Prev Med. 1987;16:710-22.
37. Mor V, Pacala JT, Rakowski W. Mammography for older women: who uses, who benefits? J Gerontol. 1992;47:43-9. Review.
38. Costanza ME. Breast cancer screening in older women: overview. J Gerontol. 1992;47:1-3.
39. Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chron Dis. 1970;23:445-68.
40. Crawlbrd J, Cohen HJ. Aging and neoplasla. Ann Rev Gerontol Geriatr. 1985;4:3-32.
41. Jaén CR, Stange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract. 1994;38:166-71.
42. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med. 1994;120:104-10.
43. Boer R, de Koning HJ, van Oortmarssen GJ, van der Maas PJ. In search of the best upper age limit for breast cancer screening. Eur J Cancer. 1995;31A(12):2040-3.
44. National Center for Health Statistics. Health. United States. 1996-97 and Injury Chartbook. Hyattsville, Md: Public Health Service: 1997:77.
45. Mandelblatt JS, Wheat ME, Monane M, Moshief RD, Hollenberg JP, Tang J. Breast cancer screening for elderly women with and without comorbid conditions. Ann Intern Med. 1992;116:722-30.
46. Fetters MD, Fischer G, Reed BD. Effectiveness of vaginal Papanicolaou smear screening after total hysterectomy for benign disease. JAMA. 1996:275(12):940-7. Review.
47. Pearce KF, Haefner HK, Sarwar SF, Nolan TE, Cytopathological findings on vaginal Papanicolaou smears after hysterectomy for benign gynecologic diseases. N Engl J Med. 1996;335(21):1559-62.
48. Etzi S, Lane DS, Grimson R. The use of mammography vans by low-income women: the accuracy of self-reports. Am J Public Health. 1994;84(1):107-9.
49. Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health. 1995;85(6): 795-800.
50. West DW, Satariano WA, Ragland DR, Hiatt RA. Comorbidity and breast cancer survival: a comparison between black and white women. Ann Epidemiol. 1996;6(5):413-9.
51. Greenfield S, Apolone G, McNeil BJ, Cleary PD. The importance of co-existing disease in the occurrence of post-operative complications and one-year recovery in patients undergoing total hip replacement. Med Care. 1993;31(2):141-54.
52. Kaplan MH, Feinstein AR. The importance of classifying initial comorbidity in evaluating the outcome of diabetes mellitus. J Chron Dis. 1974;27:387-404.
53. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Gertatr Soc. 1968;16:622-6.
54. Krousel-Wood MA, Abdoh A, Re R. Comparing comorbid-indices assessing outcome variation: the case of prostatectomy. J Gen Intern Med. 1996;11:32-8.
55. Rochon PA, Katz JN. Morrow LA, et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability: a prospective comparison of three comorbidity Indices. Med Care. 1996;34(11):1093-1101.
56. Greenfield S, Sullivan L, Dukes KA, Silliman R, D'Agostino R, Kaplan SH. Development and testing of a new measure of case mix for use in office practice. Med Care. 1995;33(4):AS47-55.
57. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics. 1996. Cancer. 1996;46(1):5-27.